Revolade 50mg Tablet

Revolade 50mg Tablet

Salt Composition: Eltrombopag

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

2x7 Tablet

About The Product

Hepatitis C

Revolade 50mg Tablet is prescribed by the doctor to treat low platelet counts in specific blood-related conditions. It is mainly given in combination with other medicines to treat a particular condition or increase effectiveness.

Revolade 50mg Tablet contains Eltrombopag that promotes the proliferation and differentiation of megakaryocytes, leading to increased platelet formation and reduced bleeding risk in conditions like chronic ITP, hepatitis C-related thrombocytopenia, or severe aplastic anemia. Take it exactly as prescribed by the doctor.

Reference

Elgebaly, A. S., Ashal, G. E., Elfil, M., & Menshawy, A. (2017). Tolerability and efficacy of eltrombopag in chronic immune thrombocytopenia: meta-analysis of randomized controlled trials. Clinical and Applied Thrombosis/Hemostasis, 23(8), 928-937 - https://pubmed.ncbi.nlm.nih.gov/27572890/

Wong, R. S., Saleh, M. N., Khelif, A., Salama, A., Portella, M. S. O., Burgess, P., & Bussel, J. B. (2017). Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood, The Journal of the American Society of Hematology, 130(23), 2527-2536 - https://pubmed.ncbi.nlm.nih.gov/29042367/

Bussel, J. B., Cheng, G., Saleh, M. N., Psaila, B., Kovaleva, L., Meddeb, B., ... & Jenkins, J. M. (2007). Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New England Journal of Medicine, 357(22), 2237-2247 - https://pubmed.ncbi.nlm.nih.gov/18046028/

Saleh, M. N., Bussel, J. B., Cheng, G., Meyer, O., Bailey, C. K., Arning, M., & Brainsky, A. (2013). Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood, The Journal of the American Society of Hematology, 121(3), 537-545. - https://pubmed.ncbi.nlm.nih.gov/23169778/

Cheng, G., Saleh, M. N., Marcher, C., Vasey, S., Mayer, B., Aivado, M., ... & Bussel, J. B. (2011). Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. The Lancet, 377(9763), 393-402.

Bussel, J. B., de Miguel, P. G., Despotovic, J. M., Grainger, J. D., Sevilla, J., Blanchette, V. S., ... & Bakshi, K. K. (2015). Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. The Lancet Haematology, 2(8), e315-e325 - https://pubmed.ncbi.nlm.nih.gov/26688484/


Side Effects

Revolade 50mg can cause multiple side effects, most of which are mild to moderate and often temporary. Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time.

  • Headache
  • Nausea
  • Tiredness
  • Diarrhea
  • Insomnia
  • Dizziness
  • Loss of Appetite
  • Rashes
  • Muscle Pain
  • Fever
  • Chills
  • Allergic Reaction
  • Liver Problem
  • Blood Clots
  • Allergic Reaction

How To Use

  • The usual dose of Revolade 50mg is one tablet daily.
  • It should be taken on an empty stomach, at the same time each day for consistent blood levels.
  • Consult your doctor for individual dosage as it may vary person to person based on its stage and overall health.
  • Eltrombopag 50mg Tablet is taken orally with the help of water.
  • Avoid breaking, chewing, biting and crushing of tablet to maintain the medication efficacy.

Safety Advice

  • Alcohol: Avoid the consumption of alcohol while taking Revolade 50mg Tablet, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.

  • Pregnancy:  Do not take Revolade 50mg Tablet  without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.

  • Breastfeeding: Breastfeeding women should discuss the potential risks and benefits of the Revolade 50mg Tablet   with their healthcare provider before starting treatment.

  • Driving: Revolade 50mg Tablet   may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.

  • Kidney:Share your medical history with the doctor before starting the Revolade 50mg Tablet  . Do not take it without consulting a doctor if you have any kidney related issue.

  • Liver: Share your medical history with the doctor before starting the Revolade 50mg Tablet  . Do not take it without consulting a doctor if you have any liver related issue.

Missed Doses

  • ​ In case you miss a dose, make sure to consult your healthcare provider for the same.
  • Do not double the dose to catch up. ​

FAQs

Revolade 50mg Tablet is used to treat low platelet counts in specific blood-related conditions.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026